Hippocampal Inhibitory Interneuron‐Specific DREADDs Treatment Alters mTORC1 ‐ 4E ‐ BP Signaling and Impairs Memory Formation
Journal of Neurochemistry · 2025
DOI: 10.1111/jnc.70048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von Ziying Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Interneurons, Mechanistic Target of Rapamycin Complex 1, Signal Transduction, Hippocampus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Control of protein synthesis via the mechanistic target of rapamycin complex 1 (mTORC1) is essential for learning and memory. However, the cell‐type‐specific and spatiotemporal regulation of this pathway during memory formation is not well understood. In this study, we expressed artificial human muscarinic M3 [hM3D(Gq)] or M4 [hM4D(Gi)] designer receptors exclusively activated by designer drugs (DREADDs) in hippocampal CA1 excitatory or inhibitory neurons of adult mice. We studied the impact of clozapine‐N‐oxide (CNO), a synthetic DREADDs agonist, on the mTORC1 pathway and long‐term memory. hM3D(Gq) and hM4D(Gi) activate or inactivate, respectively, mTORC1 signaling in hippocampal interneurons, as indicated by the phosphorylation of its targets, eukaryotic initiation factor 4E‐binding proteins (4E‐BP1/2) and ribosomal protein S6 (S6). Activation of either hM3D(Gq) or hM4D(Gi) in mice immediately after training in memory tasks impaired long‐term memory formation in inhibitory, but not in excitatory neurons. The findings underscore the importance of activity‐dependent mTORC1–4E‐BP1/2 signaling in hippocampal inhibitory interneurons for memory formation. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, McGill University, Montreal, Quebec, Canada.
- Goodman Cancer Institute, Montreal, Quebec, Canada.
- Department of Neuroscience and CIRCA, University of Montreal, Montreal, Quebec, Canada.
- Integrated Program in Neuroscience, McGill University, Montreal Neurological Institute, Montreal, Quebec, Canada.
ORCID-Profile: Ziying Huang, Niaz Mahmood, Jean-Claude Lacaille, Shane Wiebe, Nahum Sonenberg
Förderung
- Natural Sciences and Engineering Research Council of Canada
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Huang, Z., Mahmood, N., Lacaille, J. C., Wiebe, S., & Sonenberg, N. (2025). Hippocampal Inhibitory Interneuron‐Specific DREADDs Treatment Alters mTORC1 ‐ 4E ‐ BP Signaling and Impairs Memory Formation. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70048
Vancouver
Huang Z, Mahmood N, Lacaille JC, Wiebe S, Sonenberg N. Hippocampal Inhibitory Interneuron‐Specific DREADDs Treatment Alters mTORC1 ‐ 4E ‐ BP Signaling and Impairs Memory Formation. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70048
BibTeX
@article{Huang2025,
author = {Huang, Ziying and Mahmood, Niaz and Lacaille, Jean-Claude and Wiebe, Shane and Sonenberg, Nahum},
title = {Hippocampal Inhibitory Interneuron‐Specific DREADDs Treatment Alters mTORC1 ‐ 4E ‐ BP Signaling and Impairs Memory Formation},
journal = {Journal of Neurochemistry},
year = {2025},
doi = {10.1111/jnc.70048}
}
EUVIMED